Fang Du Selected Research

T 614

7/2009	Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate.
1/2008	T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fang Du Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 08/2006
10	Hypoxia (Hypoxemia) 10/2020 - 08/2007
9	Rheumatoid Arthritis 08/2021 - 01/2008
9	Ischemia 10/2015 - 05/2009
8	Inflammation (Inflammations) 01/2021 - 01/2008
8	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2012
6	Reperfusion Injury 09/2011 - 05/2009
5	Infections 01/2022 - 08/2008
5	Stroke (Strokes) 01/2022 - 04/2012
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 02/2014
5	Brain Ischemia (Cerebral Ischemia) 01/2014 - 07/2010
5	Infarction (Infarctions) 09/2011 - 07/2010
4	Ischemic Stroke 01/2020 - 01/2012
4	Medulloblastoma 01/2020 - 01/2016
4	Carcinogenesis 11/2019 - 10/2008
4	Cognitive Dysfunction 01/2018 - 02/2014
4	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2015 - 05/2010
3	Anemia 01/2022 - 01/2018
3	Lupus Nephritis 01/2022 - 01/2020
3	Pain (Aches) 12/2021 - 10/2014
3	Insulin Resistance 10/2018 - 01/2017
3	Rett Syndrome (Rett's Disorder) 01/2016 - 07/2012
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2011 - 05/2009
2	Ulcer 01/2022 - 07/2009
2	Fibrosis (Cirrhosis) 12/2021 - 03/2021
2	Multiple Myeloma 09/2021 - 12/2020
2	Esophageal Squamous Cell Carcinoma 01/2021 - 10/2020
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2019 - 01/2016
2	Body Weight (Weight, Body) 10/2018 - 01/2017
2	Iron Overload 01/2018 - 08/2015
2	Hypersensitivity (Allergy) 10/2017 - 05/2015
2	Autism Spectrum Disorder 01/2016 - 07/2012
2	Hypertension (High Blood Pressure) 12/2015 - 07/2013
2	Vasculitis (Vasculitides) 06/2015 - 01/2014
2	Chronic Periodontitis 08/2013 - 12/2012
2	Experimental Arthritis 04/2013 - 01/2008
2	Hyperthermia 02/2011 - 11/2010
2	Cerebral Infarction 11/2010 - 07/2010

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2008
8	IronIBA 12/2021 - 08/2008
6	Pharmaceutical PreparationsIBA 08/2021 - 12/2011
6	Oxygen (Dioxygen)IBA 03/2016 - 08/2007
5	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 09/2011
5	Erythropoietin FDA Link 01/2018 - 01/2008
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2013
4	Blood Glucose (Blood Sugar)IBA 12/2021 - 01/2017
4	iguratimodIBA 08/2021 - 01/2014
4	CytokinesIBA 04/2021 - 08/2008
4	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
4	Neuroprotective AgentsIBA 01/2012 - 05/2009
3	EnzymesIBA 01/2022 - 03/2015
3	Circular RNAIBA 01/2022 - 12/2020
3	MicroRNAs (MicroRNA)IBA 03/2021 - 12/2019
3	LigandsIBA 01/2020 - 12/2017
3	NestinIBA 11/2019 - 01/2016
3	Caspase 3 (Caspase-3)IBA 01/2018 - 11/2009
3	Peptides (Polypeptides)IBA 12/2017 - 08/2015
3	Biological ProductsIBA 10/2017 - 08/2006
3	Methyl-CpG-Binding Protein 2IBA 01/2016 - 07/2012
3	Methylene Blue (Methylthioninium Chloride)FDA Link 05/2013 - 01/2012
3	MicellesIBA 05/2013 - 12/2012
3	GinkgolidesIBA 02/2011 - 08/2007
2	salicylhydroxamic acid (SHAM)IBA 07/2022 - 07/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 12/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2021
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 10/2015
2	Antirheumatic Agents (DMARD)IBA 08/2021 - 01/2008
2	Long Noncoding RNAIBA 10/2020 - 01/2020
2	LuciferasesIBA 10/2020 - 06/2011
2	Small Interfering RNA (siRNA)IBA 12/2019 - 01/2009
2	Interleukin-17 (Interleukin 17)IBA 01/2019 - 04/2013
2	CholesterolIBA 10/2018 - 01/2018
2	Insulin (Novolin)FDA Link 10/2018 - 01/2017
2	HepcidinsIBA 01/2018 - 08/2015
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 11/2016
2	p38 Mitogen-Activated Protein KinasesIBA 01/2018 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 12/2017 - 03/2016
2	Deoxyribonuclease I (Nickase)IBA 10/2017 - 05/2015
2	Cyclophilins (Cyclophilin)IBA 11/2016 - 10/2015
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 05/2009
2	Gemcitabine FDA Link 11/2015 - 04/2015
2	Carrier Proteins (Binding Protein)IBA 08/2015 - 05/2014
2	Retinaldehyde (Retinal)IBA 06/2015 - 07/2013
2	NanocapsulesIBA 04/2015 - 03/2014
2	ProdrugsIBA 04/2015 - 05/2013
2	Ether (Diethyl Ether)IBA 01/2015 - 12/2011
2	Angiotensin IIIBA 05/2014 - 01/2008
2	Immunologic Factors (Immunomodulators)IBA 01/2014 - 01/2008
2	monomethoxypolyethylene glycol (MPEG)IBA 01/2014 - 05/2013
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2014 - 05/2013
2	Conditioned Culture MediaIBA 01/2013 - 09/2011
2	AntioxidantsIBA 01/2013 - 07/2010
2	MetalsIBA 04/2012 - 06/2011
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2011 - 11/2010
2	picroside IIIBA 01/2011 - 11/2010
2	ChloridesIBA 11/2010 - 07/2010
2	Glycogen Synthase KinasesIBA 11/2009 - 01/2008

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2005
2	Catheters 07/2022 - 05/2009
2	Drug Therapy (Chemotherapy) 01/2021 - 12/2020